Back to results
US 2020/0347048 A1Published application
Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manouchehr Shahbaz
Life of this patent
Estimating the term…
Abstract
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
Claims20
A compound having the structural formula
- wherein each position represented as D has deuterium enrichment of no less than about 10%.
Dependencies are inferred from the claim text.